CMND (clearmindmedicine.com) Nilai Buku saben Saham

Clearmind Medicine Inc. (CMND) is developing innovative MEAI drugs to combat addictions. The book value per share on the GURU.Markets consolidated chart contains up-to-date data, where 48.15 serves as the final level mark. The company's prospects rely on a team of leading neurologists and stringent patent barriers that limit the entry of new players into the highly regulated psychiatry sector.

The BVPS trend on the GURU.Markets platform reflects the actual asset base of Clearmind Medicine Inc. (CMND), which, given the non-cyclical nature of the biotech sector, depends exclusively on R&D efficiency. This indicator is calculated as the ratio of net assets to the number of shares outstanding, allowing investors to assess the intrinsic value of capital regardless of market volatility and macroeconomic risks.